United States · FDA National Drug Code directory
ADCETRIS
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51144-050_a695c1a2-3acc-468b-a829-c8761dc041f6
- Product NDC
- 51144-050
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- brentuximab vedotin
- Labeler
- SEAGEN INC.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20110825
- Source listing expiry
- 20261231
Source-listed ingredients
- BRENTUXIMAB VEDOTIN — 50 mg/10.5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-DOSE in 1 BOX (51144-050-01) / 10.5 mL in 1 VIAL, SINGLE-DOSE · 51144-050-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →